VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Xu, Chengshi ^a   Wu, Xing ^a   Zhu, Jianhong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CARBANILAMIDE DERIVATIVE; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; N (2,4 DIFLUOROPHENYL) N' (4 ((6,7 DIMETHOXY 4 QUINOLYL)OXY) 2 FLUOROPHENYL)UREA; N-(2,4-DIFLUOROPHENYL)-N'-(4-((6,7-DIMETHOXY-4-QUINOLYL)OXY)-2-FLUOROPHENYL)UREA; PEPTIDE; QUINOLINE DERIVATIVE; VASCULOTROPIN A;

ARTICLE; ATP ASSAY; BIOASSAY; CANCER STEM CELL; CANCER STEM LIKE CELL; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NEURAL COLONY FORMING CELL ASSAY; SIGNAL TRANSDUCTION; CELL CULTURE; CELL HYPOXIA; CELL SHAPE; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION;

ANTIGENS, CD; CELL HYPOXIA; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PHENYLUREA COMPOUNDS; PHOSPHORYLATION; QUINOLINES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84875640859     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/417413     Document Type: Article

References (33)

1. Greenberg D. A., Jin K., From angiogenesis to neuropathology. Nature 2005 438 7070 954 959 2-s2.0-30744477950 10.1038/nature04481 (Pubitemid 43093961)
2. Mackenzie F., Ruhrberg C., Diverse roles for VEGF-A in the nervous system. Development 2012 139 1371 1380
3. Rosenstein J. M., Krum J. M., New roles for VEGF in nervous tissue-beyond blood vessels. Experimental Neurology 2004 187 2 246 253 2-s2.0-2342667384 10.1016/j.expneurol.2004.01.022 (Pubitemid 38610271)
4. Cheshier S. H., Kalani M. Y. S., Lim M., Ailles L., Huhn S. L., Weissman I. L., A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells. Neurosurgery 2009 65 2 237 249 2-s2.0-70349331502 10.1227/01.NEU.0000349921.14519.2A
5. Piccirillo S. G. M., Binda E., Fiocco R., Vescovi A. L., Shah K., Brain cancer stem cells. Journal of Molecular Medicine 2009 87 11 1087 1095 2-s2.0-70449521447 10.1007/s00109-009-0535-3
6. Takakura N., Formation and regulation of the cancer stem cell niche. Cancer Science 2012 103 1177 1181
7. Zhu T. S., Costello M. A., Talsma C. E., Endothelial cells create a stem cell niche in glioblastoma by providing notch ligands that nurture self-renewal of cancer stem-like cells. Cancer Research 2011 71 6061 6072
8. Hamerlik P., Lathia J. D., Rasmussen R., Autocrine VEGF-VEGFR2- neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. The Journal of Experimental Medicine 2012 209 507 520
9. Jinushi M., Baghdadi M., Chiba S., Yoshiyama H., Regulation of cancer stem cell activities by tumor-associated macrophages. American Journal of Cancer Research 2012 2 529 539
10. Heddleston J. M., Li Z., Lathia J. D., Bao S., Hjelmeland A. B., Rich J. N., Hypoxia inducible factors in cancer stem cells. British Journal of Cancer 2010 102 5 789 795 2-s2.0-77649273107 10.1038/sj.bjc.6605551
11. Keith B., Simon M. C., Hypoxia-inducible factors, stem cells, and cancer. Cell 2007 129 3 465 472 2-s2.0-34247527730 10.1016/j.cell.2007.04.019 (Pubitemid 46660978)
12. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R. E., Hjelmeland A. B., Rich J. N., Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009 15 6 501 513 2-s2.0-65749106405 10.1016/j.ccr.2009.03.018
13. Folkins C., Shaked Y., Man S., Tang T., Lee C. R., Zhu Z., Hoffman R. M., Kerbel R. S., Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Research 2009 69 18 7243 7251 2-s2.0-70349747011 10.1158/0008-5472. CAN-09-0167
14. Mentlein R., Forstreuter F., Mehdorn H. M., Held-Feindt J., Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. Journal of Neuro-Oncology 2004 67 1-2 9 18 2-s2.0-1842432622 10.1023/B:NEON.0000021737.89357.cc (Pubitemid 38418244)
15. Xiao Z., Kong Y., Yang S., Li M., Wen J., Li L., Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation. Cell Research 2007 17 1 73 79 2-s2.0-33846186883 10.1038/sj.cr.7310126 (Pubitemid 46096427)
16. Zhao D., Najbauer J., Garcia E., Metz M. Z., Gutova M., Glackin C. A., Kim S. U., Aboody K. S., Neural stem cell tropism to glioma: critical role of tumor hypoxia. Molecular Cancer Research 2008 6 12 1819 1829 2-s2.0-57749089644 10.1158/1541-7786.MCR-08-0146
17. Bruns A. F., Bao L., Walker J. H., Ponnambalam S., VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis. Biochemical Society Transactions 2009 37 6 1193 1197 2-s2.0-70450174358 10.1042/BST0371193
18. Olsson A. K., Dimberg A., Kreuger J., Claesson-Welsh L., VEGF receptor signalling-in control of vascular function. Nature Reviews Molecular Cell Biology 2006 7 5 359 371 2-s2.0-33646107369 10.1038/nrm1911
19. Hadjipanayis C. G., Van Meir E. G., Brain cancer propagating cells: biology, genetics and targeted therapies. Trends in Molecular Medicine 2009 15 11 519 530 2-s2.0-70449099233 10.1016/j.molmed.2009.09.003
20. Roberts D. M., Kearney J. B., Johnson J. H., Rosenberg M. P., Kumar R., Bautch V. L., The vascular endothelial growth factor (VEGF) receptor flt-1 (VEGFR-1) modulates flk-1 (VEGFR-2) signaling during blood vessel formation. American Journal of Pathology 2004 164 5 1531 1535 2-s2.0-1942437424 (Pubitemid 38529755)
21. Kappas N. C., Zeng G., Chappell J. C., Kearney J. B., Hazarika S., Kallianos K. G., Patterson C., Annex B. H., Bautch V. L., The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. Journal of Cell Biology 2008 181 5 847 858 2-s2.0-44649128099 10.1083/jcb.200709114 (Pubitemid 351786988)
22. Sela S., Natanson-Yaron S., Zcharia E., Vlodavsky I., Yagel S., Keshet E., Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase. Circulation Research 2011 108 9 1063 1070 2-s2.0-79955582750 10.1161/CIRCRESAHA.110.239665
23. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A. B., Shi Q., McLendon R. E., Bigner D. D., Rich J. N., Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research 2006 66 16 7843 7848 2-s2.0-33748051406 10.1158/0008-5472.CAN-06-1010 (Pubitemid 44299144)
24. Linkous A. G., Yazlovitskaya E. M., Angiogenesis in glioblastoma multiforme: navigating the maze. Anti-Cancer Agents in Medicinal Chemistry 2011 11 712 718
25. Robles Irizarry L., Hambardzumyan D., Nakano I., Gladson C. L., Ahluwalia M. S., Therapeutic targeting of VEGF in the treatment of glioblastoma. Expert Opinion on Therapeutic Targets 2012 16 973 984
26. Chi A. S., Sorensen A. G., Jain R. K., Batchelor T. T., Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009 14 6 621 636 2-s2.0-68049113584 10.1634/theoncologist.2008-0272
27. Hu Y. L., DeLay M., Jahangiri A., Molinaro A. M., Rose S. D., Carbonell W. S., Aghi M. K., Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Research 2012 72 1773 1783
28. Bikfalvi A., Moenner M., Javerzat S., North S., Hagedorn M., Inhibition of angiogenesis and the angiogenesis/invasion shift. Biochemical Society Transactions 2011 39 1560 1564
29. Keunen O., Johansson M., Oudin A., Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America 2011 108 3749 3754
30. Norden A. D., Drappatz J., Wen P. Y., Antiangiogenic therapies for high-grade glioma. Nature Reviews Neurology 2009 5 11 610 620 2-s2.0-70449517400 10.1038/nrneurol.2009.159
31. Chamberlain M. C., Antiangiogenic blockage: a new treatment for glioblastoma. Expert Opinion on Biological Therapy 2008 8 10 1449 1453 2-s2.0-54349111868 10.1517/14712598.8.10.1449
32. Heddleston J. M., Wu Q., Rivera M., Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death & Differentiation 2012 19 428 439
33. Tang H., Gong Y., Mao Y., Cd133-positive cells might be responsible for efficient proliferation of human meningioma cells. International Journal of Molecular Sciences 2012 13 6424 6439